US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi Genomics & Precision Medicine ETF

37.52

+1.413.90%

Post-market: 37.520.00000.00%16:10 EDT

Volume:526

Turnover:19.69K

Market Cap:1.31M

PE:- -

High:37.59

Open:37.25

Low:37.25

Close:36.11

52wk High:39.65

52wk Low:23.88

Shares:35.00K

Float Shares:35.00K

Volume Ratio:0.09

T/O Rate:1.50%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Waters Corp. Stock Outperforms Competitors on Strong Trading Day

Vertex Pharmaceuticals to present data on Alyftrek at NACFC

Vertex Says Interim Alyftrek Study Data Show Some CF Children Ages 2-5 Regain Pancreatic Function

Vertex and Moderna Advance CF mRNA Therapy: What VX-522 Trial Completion Means for Investors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/GNMX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GNMX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","market":"US","secType":"STK","nameCN":"Corgi Genomics & Precision Medicine ETF","latestPrice":37.5169,"timestamp":1791576000000,"preClose":36.107,"halted":0,"volume":526,"hourTrading":{"tag":"盘后","latestPrice":37.5169,"preClose":37.5169,"latestTime":"16:10 EDT","volume":2,"amount":75.0338,"timestamp":1791576603623,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.03904783006065307,"floatShares":35000,"shares":35000,"eps":0,"marketStatus":"Post-Mkt","change":1.4099,"latestTime":"10-09 18:59:05 EDT","open":37.25,"high":37.59,"low":37.25,"amount":19686,"amplitude":0.009416,"askPrice":56.28,"askSize":200,"bidPrice":18.76,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791590400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1302235200000,"exchange":"CBOE","adjPreClose":36.107,"nav":36.43,"aum":1275050,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":37.5169,"preClose":37.5169,"latestTime":"16:10 EDT","volume":2,"amount":75.0338,"timestamp":1791576603623,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.090183,"impliedVol":0.1888,"impliedVolPercentile":0.43},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","floatShares":35000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.090183,"shares":35000,"dividePrice":0,"high":37.59,"amplitude":0.009416,"preClose":36.107,"low":37.25,"week52Low":23.88,"pbRate":"--","week52High":39.645,"institutionHeld":0,"latestPrice":37.5169,"eps":0,"divideRate":0,"volume":526,"delay":0,"ttmEps":0,"open":37.25,"prevYearClose":25.56,"prevWeekClose":37.73,"prevMonthClose":38.3481,"prevQuarterClose":38.3481,"fiveDayClose":37.73,"twentyDayClose":34.1467,"sixtyDayClose":31.0031},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNMX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNMX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNMX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNMX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674864359","title":"Waters Corp. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2674864359","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674864359?lang=en_us&edition=fundamental","pubTime":"2026-10-10 04:51","pubTimestamp":1791579060,"startTime":"0","endTime":"0","summary":"DJ Waters Corp. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Waters Corp.  advanced 1.08% to $433.77 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.59% to 7,811.54 and the Dow Jones Industrial Average  rising 0.83% to 51,654.95.The stock's rise snapped a three-day losing streak.Waters Corp. closed 4.57% short of its 52-week high of $454.54, which the company reached on October 6th.The stock outperformed some of its competitors Friday, as Thermo Fisher Scientific Inc.  rose 0.93% to $658.02, Danaher Corp.  rose 1.08% to $219.81, and GE Aerospace  rose 0.84% to $308.20.Trading volume  eclipsed its 50-day average volume of 769,429.Data source: Dow Jones Market Data, FactSet. Data compiled October 9, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765059.SGD","EXI","LU1633808545.USD","LU2543165471.USD","LU0109391861.USD","TRUI","DFEN","ITA","DHR","LU0354030511.USD","LU1670627923.USD","IE00B1BXHZ80.USD","GE","LU0820561909.HKD","BK4543","UXI","BK4534","LU2360108059.USD","LU2125910336.SGD","LU0187121727.USD","LU0289961442.SGD","LU2168564495.EUR","LU1093756325.SGD","HRTS","MISL","LU0345770993.USD","TMED","PPA","BK4588","LU2089984988.USD","SG9999004303.SGD","LU1989771016.USD","XAR","BK4535","LU1551013342.USD","LU0128525929.USD","LU1712237335.SGD","GNMX","LU1670628061.USD","LU2211814178.USD","NATO","SGXZ57979304.SGD","IE0034235188.USD","TMO","LU0210536198.USD","BK4585","LU1923622291.USD","FMED","LU0728928796.USD","WAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674866511","title":"Vertex Pharmaceuticals to present data on Alyftrek at NACFC","url":"https://stock-news.laohu8.com/highlight/detail?id=2674866511","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674866511?lang=en_us&edition=fundamental","pubTime":"2026-10-10 01:20","pubTimestamp":1791566419,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals (VRTX) announced new interim data from the ALYFTREK 2 to 5 years old open-label extension study, highlighting recovery of ex...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-to-present-data-on-alyftrek-at-nacfc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-to-present-data-on-alyftrek-at-nacfc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1585245621.USD","IDNA","LU2237438978.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IBB","BK4588","IE00BZ9MQY76.HKD","LU2089984988.USD","SG9999001176.USD","VERX","VRTX","LU1093756325.SGD","SG9999013999.USD","LU0320765992.SGD","LU2362541273.HKD","BK4533","SG9999001176.SGD","GNMX","IE0009355771.USD","BK4023","LU0417517546.SGD","IE00B894F039.SGD","BBH","LU0289739699.SGD","IE00B19Z9P08.USD","LU1035775433.USD","BK4567","LU0109394709.USD","LU2324357040.USD","BK4139","LU1674673428.USD","BIB","IBBQ","TBXU","LU2236285917.USD","IE00B19Z3B42.SGD","BK4532","IE00B2B36J28.USD","LU1778281490.HKD","LU2468319806.SGD","PBE","IE00B4R5TH58.HKD","LU0234570918.USD","LU0061475181.USD","LU1674673691.USD","LU0432979614.USD","IE0002270589.USD","IE00BJT1NW94.SGD","LU0256863811.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674865094","title":"Vertex Says Interim Alyftrek Study Data Show Some CF Children Ages 2-5 Regain Pancreatic Function","url":"https://stock-news.laohu8.com/highlight/detail?id=2674865094","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674865094?lang=en_us&edition=fundamental","pubTime":"2026-10-10 01:15","pubTimestamp":1791566131,"startTime":"0","endTime":"0","summary":"Vertex says interim ALYFTREK study data show some CF children ages 2-5 regain pancreatic functionVertex flagged interim trial data on ALYFTREK showing some cystic fibrosis children ages 2 to 5 regaine","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nNDL2tJqZ6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0079474960.USD","LU2237438978.USD","IE00B19Z3B42.SGD","LU0109394709.USD","LU0289739699.SGD","IE0002270589.USD","LU0320765992.SGD","LU0234570918.USD","LU2362541273.HKD","TBXU","GNMX","IDNA","BK4533","LU0823416689.USD","IE00B19Z3581.USD","LU0417517546.SGD","LU2417539215.USD","LU0889565916.HKD","BK4532","LU0058720904.USD","LU1674673691.USD","SG9999013999.USD","IE00B2B36J28.USD","IE00BZ9MQY76.HKD","LU1674673428.USD","IE00B19Z9Z06.USD","LU2362541513.USD","IE0002141913.USD","LU2324357040.USD","BK4139","IE00B894F039.SGD","SG9999001176.SGD","IE00B4R5TH58.HKD","VRTX","PBE","BBH","LU2468319806.SGD","BIB","BK4585","LU1069344957.HKD","LU1778281490.HKD","IBBQ","LU1093756325.SGD","LU2089984988.USD","IE00BJT1NW94.SGD","IBB","LU0432979614.USD","LU2462157665.USD","LU1093756168.USD","LU0061475181.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674902865","title":"Vertex and Moderna Advance CF mRNA Therapy: What VX-522 Trial Completion Means for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2674902865","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674902865?lang=en_us&edition=fundamental","pubTime":"2026-10-10 00:30","pubTimestamp":1791563440,"startTime":"0","endTime":"0","summary":"Moderna ($MRNA), Vertex Pharmaceuticals Inc. ($VRTX) announced an update on their ongoing clinical study. The Phase 1/2 study titled “A Phase 1/2 D...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-and-moderna-advance-cf-mrna-therapy-what-vx-522-trial-completion-means-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-and-moderna-advance-cf-mrna-therapy-what-vx-522-trial-completion-means-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2324357040.USD","BK4501","IE0009355771.USD","SG9999001176.SGD","LU2237438978.USD","PBE","LU2362541513.USD","IE0002270589.USD","LU1585245621.USD","IE00B894F039.SGD","MRNY","IE00B4R5TH58.HKD","LU0566484027.USD","ISBC","LU1069344957.HKD","IE00BJJMRZ35.SGD","MRNA","IBBQ","IE00BJT1NW94.SGD","LU0061475181.USD","VERX","LU2362541273.HKD","WDNA","LU2362540622.SGD","BBH","BK4588","GNMX","LU1093756168.USD","VRTX","IE00B2B36J28.USD","LU0289739699.SGD","LU0889565916.HKD","IE00B19Z9P08.USD","BK4551","LGHT","BK4585","MRNX","GNOM","LU0320765992.SGD","BIB","TBXU","IE00BFTCPJ56.SGD","BK4139","IDNA","IBB","BK4567","LU0757428866.USD","LU1778281490.HKD","BK4548","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/GNMX\",params:#limit:6,delay:false,,,undefined,":[]}}